GB Patent

GB2023594A — 1-substituted alkyl-4-(3- trifluoromethylthiophenyl)- piperazines

Assigned to Synthelabo SA · Expires 1980-01-03 · 46y expired

What this patent protects

Compounds having the general formula (I> <IMAGE> in which n is 1, 2 or 3 and R represents (i) a group of formula: <IMAGE> (A) in which R1 and R2 represent hydrogen atoms or together represent a group of formula: <IMAGE> thereby completing a benzene ring …

USPTO Abstract

Compounds having the general formula (I> <IMAGE> in which n is 1, 2 or 3 and R represents (i) a group of formula: <IMAGE> (A) in which R1 and R2 represent hydrogen atoms or together represent a group of formula: <IMAGE> thereby completing a benzene ring fused to the heterocyclic ring shown in formula (A), X is a -S-, -O-, imino, alkyl-imino or methylene group and m is 0 or 1 or R represents (ii) a group of formula: <IMAGE> (B), (iii) a 2-tetrahydrofuryl group, (iv) a group of formula -CH2-S-Z, Z representing a hydrogen atom, alkyl group or -CO- alkyl group or (v) a group of formula -CH2-O- alkyl, having from 1 to 8 carbon atoms, and their pharmaceutically acceptable acid addition salts are useful in therapy, especially for treatment of anxiety and depression.

Drugs covered by this patent

Patent Metadata

Patent number
GB2023594A
Jurisdiction
GB
Classification
Expires
1980-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Synthelabo SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.